{"transactions":[{"id":1862387,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T16:48:19.000Z","date":"2023-06-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":76595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than $0.91 and was outstanding immediately prior to the Effective Time was terminated and canceled immediately prior to the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":1.04,"underlying":"Common Stock","underlying_shares":76595},"source":{"system":"sec-edgar","filing":"0000899243-23-014901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014901/doc4.xml","form_type":"4"}},{"id":1862386,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T16:48:19.000Z","date":"2023-06-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":72340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than $0.91 and was outstanding immediately prior to the Effective Time was terminated and canceled immediately prior to the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":4.56,"underlying":"Common Stock","underlying_shares":72340},"source":{"system":"sec-edgar","filing":"0000899243-23-014901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014901/doc4.xml","form_type":"4"}},{"id":1862385,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T16:48:19.000Z","date":"2023-06-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than $0.91 and was outstanding immediately prior to the Effective Time was terminated and canceled immediately prior to the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.46,"underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0000899243-23-014901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014901/doc4.xml","form_type":"4"}},{"id":1862384,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T16:48:19.000Z","date":"2023-06-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than $0.91 and was outstanding immediately prior to the Effective Time was terminated and canceled immediately prior to the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":4.6,"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000899243-23-014901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014901/doc4.xml","form_type":"4"}},{"id":1862383,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-06-08T16:48:19.000Z","date":"2023-06-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than $0.91 and was outstanding immediately prior to the Effective Time was terminated and canceled immediately prior to the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the \"Shares\") of the Issuer with an exercise price that is less than the $0.91 that is outstanding immediately prior to the date and time at which the Merger became effective (the \"Effective Time\") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":29,"underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-23-014901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014901/doc4.xml","form_type":"4"}},{"id":1862382,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-06-08T16:48:19.000Z","date":"2023-06-06","kind":"other","planned":false,"acquired":false,"shares":13877,"price":0.91,"value":12628.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of to SNBL23 Merger Sub, Inc. (\"Merger Sub\"), which, pursuant to the Agreement and Plan of Merger, dated April 16, 2023, by and between the Issuer, Shin Nippon Biomedical Laboratories, Ltd., a Japanese corporation (\"Parent\"), and Merger Sub (the \"Merger Agreement\"), commenced a tender offer to acquire any and all of the outstanding shares of the Issuer's common stock at a purchase price of $0.91 per share and one non-transferable contractual contingent value right (the \"Offer Price\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-014901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000089924323014901/doc4.xml","form_type":"4"}},{"id":2240299,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T17:40:18.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty Five Percent (25%) of the shares subject to the option vest one year measured from June 3, 2022 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":190000,"derivative":{"exercise_price":3.46,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001567619-22-012481","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761922012481/doc1.xml","form_type":"4"}},{"id":2955261,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-07T18:02:43.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty Five Percent (25%) of the shares subject to the option vest one year measured from December 3, 2020 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":4.6,"expiration_date":"2030-12-03","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001567619-20-020718","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920020718/doc1.xml","form_type":"4"}},{"id":3039413,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T16:05:15.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":65590,"derivative":{"exercise_price":4.56,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001567619-20-016411","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/doc1.xml","form_type":"4"}},{"id":3039412,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-09-03T16:05:15.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":750,"price":22.1927,"value":16644.525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $21.90 to $22.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-016411","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/doc1.xml","form_type":"4"}},{"id":3039411,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-09-03T16:05:15.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":750,"price":4.56,"value":3420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001567619-20-016411","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/doc1.xml","form_type":"4"}},{"id":3064884,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-07T18:40:40.000Z","date":"2020-08-05","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":66340,"derivative":{"exercise_price":4.56,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001567619-20-014527","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/doc1.xml","form_type":"4"}},{"id":3064883,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-08-07T18:40:40.000Z","date":"2020-08-05","kind":"sale","acquired":false,"shares":1000,"price":25,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-014527","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/doc1.xml","form_type":"4"}},{"id":3064882,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-08-07T18:40:40.000Z","date":"2020-08-05","kind":"exercise","acquired":true,"shares":1000,"price":4.56,"value":4560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001567619-20-014527","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/doc1.xml","form_type":"4"}},{"id":3092112,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:15:21.000Z","date":"2020-07-01","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":67340,"derivative":{"exercise_price":4.56,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001567619-20-012820","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/doc1.xml","form_type":"4"}},{"id":3092111,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-07-02T16:15:21.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":306,"price":27.5936,"value":8443.6416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $27.50 to $27.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-012820","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/doc1.xml","form_type":"4"}},{"id":3092110,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-07-02T16:15:21.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":306,"price":4.56,"value":1395.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":306,"source":{"system":"sec-edgar","filing":"0001567619-20-012820","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/doc1.xml","form_type":"4"}},{"id":3092109,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-07-02T16:15:21.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":394,"price":26.7007,"value":10520.0758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $26.40 to $27.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-012820","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/doc1.xml","form_type":"4"}},{"id":3092108,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-07-02T16:15:21.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":394,"price":4.56,"value":1796.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":394,"source":{"system":"sec-edgar","filing":"0001567619-20-012820","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/doc1.xml","form_type":"4"}},{"id":3092107,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-07-02T16:15:21.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":300,"price":25.634,"value":7690.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $25.35 to $26.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-012820","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/doc1.xml","form_type":"4"}},{"id":3092106,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-07-02T16:15:21.000Z","date":"2020-07-01","kind":"exercise","acquired":true,"shares":300,"price":4.56,"value":1368.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001567619-20-012820","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/doc1.xml","form_type":"4"}},{"id":3100944,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T16:53:31.000Z","date":"2020-06-23","kind":"exercise","acquired":false,"shares":2115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty Five Percent (25%) of the shares subject to the option vest one year measured from January 14, 2019 (the \"Vesting Commencement Date\") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":74480,"derivative":{"exercise_price":1.04,"expiration_date":"2029-01-29","underlying":"Common Stock","underlying_shares":2115},"source":{"system":"sec-edgar","filing":"0001567619-20-012533","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/doc1.xml","form_type":"4"}},{"id":3100943,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-06-24T16:53:31.000Z","date":"2020-06-23","kind":"sale","acquired":false,"shares":2115,"price":35.2302,"value":74511.873,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $35.00 to $35.54, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-012533","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/doc1.xml","form_type":"4"}},{"id":3100942,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-06-24T16:53:31.000Z","date":"2020-06-23","kind":"exercise","acquired":true,"shares":2115,"price":1.04,"value":2199.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2115,"source":{"system":"sec-edgar","filing":"0001567619-20-012533","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/doc1.xml","form_type":"4"}},{"id":3127200,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T19:31:39.000Z","date":"2020-06-01","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":68340,"derivative":{"exercise_price":4.56,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001567619-20-011564","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/doc1.xml","form_type":"4"}},{"id":3127199,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-06-02T19:31:39.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":1000,"price":25.3235,"value":25323.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $25.00 to $25.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-011564","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/doc1.xml","form_type":"4"}},{"id":3127198,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-06-02T19:31:39.000Z","date":"2020-06-01","kind":"exercise","acquired":true,"shares":1000,"price":4.56,"value":4560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001567619-20-011564","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/doc1.xml","form_type":"4"}},{"id":3139267,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-21T17:34:32.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":69340,"derivative":{"exercise_price":4.56,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001567619-20-010950","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/doc1.xml","form_type":"4"}},{"id":3139266,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-05-21T17:34:32.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":2000,"price":25,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-010950","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/doc1.xml","form_type":"4"}},{"id":3139265,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-05-21T17:34:32.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":2000,"price":4.56,"value":9120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001567619-20-010950","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/doc1.xml","form_type":"4"}},{"id":3213630,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-12T17:31:45.000Z","date":"2020-03-11","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":71340,"derivative":{"exercise_price":4.56,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001567619-20-006202","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/doc1.xml","form_type":"4"}},{"id":3213629,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-03-12T17:31:45.000Z","date":"2020-03-11","kind":"sale","acquired":false,"shares":1000,"price":27.678,"value":27678.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $26.95 to $29.43, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-006202","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/doc1.xml","form_type":"4"}},{"id":3213628,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-03-12T17:31:45.000Z","date":"2020-03-11","kind":"exercise","acquired":true,"shares":1000,"price":4.56,"value":4560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001567619-20-006202","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/doc1.xml","form_type":"4"}},{"id":3222798,"issuer":{"id":112442,"kind":"organization","name":"Satsuma Pharmaceuticals, Inc.","symbol":"STSA"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-06T16:07:17.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty Five Percent (25%) of the shares subject to the option vest one year measured from March 4, 2020 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":29,"expiration_date":"2030-03-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001567619-20-005799","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1692830/000156761920005799/doc1.xml","form_type":"4"}},{"id":3840206,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-17T20:29:55.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":14050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the total number of shares underlying this option shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020."}],"balance_after":14050,"derivative":{"exercise_price":8.58,"expiration_date":"2028-08-14","underlying":"Common Stock","underlying_shares":14050},"source":{"system":"sec-edgar","filing":"0001209191-18-047549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919118047549/doc4.xml","form_type":"4"}},{"id":3840205,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-17T20:29:55.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":21100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of the restricted stock units payable solely in common stock that vest as follows: 1/3rd of the total number of shares shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 602 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2018."}],"balance_after":30560,"source":{"system":"sec-edgar","filing":"0001209191-18-047549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919118047549/doc4.xml","form_type":"4"}},{"id":4020186,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-02T19:20:09.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option shall vest as to 25% after one year following the grant date, and the remainder will vest in equal monthly installments over the following three years."}],"balance_after":34000,"derivative":{"exercise_price":16.95,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001209191-18-016035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919118016035/doc4.xml","form_type":"4"}},{"id":4020185,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-02T19:20:09.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,572 shares and 1,286 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2017 and September 8, 2017, respectively."}],"balance_after":8858,"source":{"system":"sec-edgar","filing":"0001209191-18-016035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919118016035/doc4.xml","form_type":"4"}},{"id":4125054,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-12-20T21:08:57.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date."}],"balance_after":28998,"derivative":{"exercise_price":4.21,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-17-066697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919117066697/doc4.xml","form_type":"4"}},{"id":4125053,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-12-20T21:08:57.000Z","date":"2017-12-18","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date."}],"balance_after":57666,"derivative":{"exercise_price":1.16,"expiration_date":"2026-02-08","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-17-066697","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919117066697/doc4.xml","form_type":"4"}},{"id":4125052,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"12/18/2017","published_at":"2017-12-20T21:08:57.000Z","date":"2017-12-18","kind":"sale","acquired":false,"shares":8000,"price":20,"value":160000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-066697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919117066697/doc4.xml","form_type":"4"}},{"id":4125051,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-20T21:08:57.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":4000,"price":4.21,"value":16840.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-17-066697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919117066697/doc4.xml","form_type":"4"}},{"id":4125050,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-20T21:08:57.000Z","date":"2017-12-18","kind":"exercise","acquired":true,"shares":4000,"price":1.16,"value":4640.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-17-066697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919117066697/doc4.xml","form_type":"4"}},{"id":4580179,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":112569,"kind":"person","name":"O'Neil Thomas P.","position":1,"cik":"0001640645","reported_name":"O'Neil Thomas P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-13T16:27:33.000Z","date":"2016-10-11","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 48 equal monthly installments from the vesting commencement date of August 10, 2016."}],"balance_after":45000,"derivative":{"exercise_price":21.58,"expiration_date":"2026-10-11","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-16-145801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640645/000120919116145801/doc4.xml","form_type":"4"}}]}